http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102603613-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
filingDate 2012-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102603613-B
titleOfInvention 4-(methoxycarbonyl)-4-(N- phenylpropionamido)- piperidine-1-substituted compound, preparation method and pharmaceutical application
abstract The invention relates to a 4-(methoxycarbonyl)-4-(N-phenylpropionamido)-piperidine-1-substituted compound, a preparation method and pharmaceutical application. The compound is of a structure of free base in a formula (I) or corresponding hydrochloride (I'), wherein in the formula, n is an integral number in the range of 0 to 3 and R is a sulfonyl group or a substituent group with a propofol parent nucleus structure. The compound has excellent water-solubility and stability and can simultaneously have effects of alleviating pain and calming, is suitable for carrying out pain alleviation and calming on a postoperative monitored patient and is particularly beneficial for implementing the operation of the patient on a self-control drug delivery system and the operation of an anesthetist can be reduced. The basic method for preparing the compound comprises the following step that according to the property of the substituent group R, the 4-(methoxycarbonyl)-4-(N-phenylpropionamido)-piperidine-1-substituted compound can be formed by carrying out condensation on a compound with a remifentanil parent nucleus structure and a compound with a corresponding substituent group parent nucleus structure. The invention provides the 4-(methoxycarbonyl)-4-(N-phenylpropionamido)-piperidine-1-substituted compound.
priorityDate 2012-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008134525-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102344408-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426021340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410068132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415758737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448769888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449831254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3251421
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67406281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412216270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10967
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420921434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86738798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4186634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455581532

Total number of triples: 58.